Excess Mortality among HIV-infected Individuals with Cancer in the United States
Supporting Files
-
Jun 15 2017
-
File Language:
English
Details
-
Alternative Title:Cancer Epidemiol Biomarkers Prev
-
Personal Author:
-
Description:Background
HIV-infected persons are living longer in the era of effective HIV treatment, resulting in an increasing cancer burden in this population. The combined effects of HIV and cancer on mortality are incompletely understood.
Methods
We examined whether individuals with both HIV and cancer have excess mortality using data from the HIV/AIDS Cancer Match Study and the National Center for Health Statistics (1996–2010). We compared age, sex, and race-stratified mortality between people with and without HIV or one of the following cancers: lung, breast, prostate, colorectum, anus, Hodgkin lymphoma, or non-Hodgkin lymphoma. We utilized additive Poisson regression models that included terms for HIV, cancer, and an interaction for their combined effect on mortality. We report the number of excess deaths per 1,000 person-years for models with a significant interaction (P<0.05).
Results
For all cancers examined except prostate cancer, at least one demographic subgroup of HIV-infected cancer patients experienced significant excess mortality. Excess mortality was most pronounced at younger ages (30–49 years), with large excesses for males with lung cancer (white race:573 per 1,000 person-years; non-white:503) and non-Hodgkin lymphoma (white:236; non-white:261), and for females with Hodgkin lymphoma (white:216; non-white:136) and breast cancer (non-white:107).
Conclusion
In the era of effective HIV treatment, overall mortality in patients with both HIV and cancer was significantly higher than expected based on mortality rates for each disease separately.
Impact
These results suggest that HIV may contribute to cancer progression and highlight the importance of improved cancer prevention and care for the US HIV population.
-
Subjects:
-
Source:Cancer Epidemiol Biomarkers Prev. 26(7):1027-1033.
-
Pubmed ID:28619832
-
Pubmed Central ID:PMC5500417
-
Document Type:
-
Funding:U58 DP003931/DP/NCCDPHP CDC HHS/United States ; U62 PS004011/PS/NCHHSTP CDC HHS/United States ; Z99 CA999999/NULL/Intramural NIH HHS/United States ; U58 DP003875/DP/NCCDPHP CDC HHS/United States ; HHSN261201300021C/CA/NCI NIH HHS/United States ; U58 DP000848/DP/NCCDPHP CDC HHS/United States ; U58 DP000812/DP/NCCDPHP CDC HHS/United States ; HHSN261201000024C/CA/NCI NIH HHS/United States ; U62 PS001005/PS/NCHHSTP CDC HHS/United States ; U62 PS004001/PS/NCHHSTP CDC HHS/United States ; U58 DP000824/DP/NCCDPHP CDC HHS/United States
-
Place as Subject:
-
Volume:26
-
Issue:7
-
Collection(s):
-
Main Document Checksum:urn:sha256:43d45f847c5f80bcbfdfe6a33b38c5563d496d9b0af774e5ba2064b0d1d252e5
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access